CA19-9-negative pancreatic cancer mimicking renal cancer

British Journal of Urology

Volumn 77, Issue 5, 1996, Pages 757-758

  Mi, O ^a,b   Raishi, ^a   Kinebcchi, Y ^a   Ogawa, A ^a  

^a Shinshu University   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN;

ADENOSQUAMOUS CARCINOMA; ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEMAGGLUTINATION TEST; HUMAN; KIDNEY ARTERIOGRAPHY; KIDNEY CARCINOMA; LIVER METASTASIS; NEPHRECTOMY; PANCREAS CARCINOMA; PANCREAS RESECTION; PRIORITY JOURNAL; SPLEEN CANCER; SPLENECTOMY;

CA-19-9 ANTIGEN; CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; KIDNEY NEOPLASMS; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030417512     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Del Villano BC, Brennan S, Brock P et al. Radioimmunometric assay for a monoclonal antibody-defined tumor. Clin Chem 1983: 29: 549-52
2. Pour PM, Tempero MM. Takasaki H. Uchida E, Takiyama Y, Burnett DA, Steplewski Z. Expression of blood group-related antigens ABH, Lewis A. Lewis B, Lewis X, Lewis Y. and CA19-9 in pancreatic cancer cells in comparison with the patient's blood group type. Cancer Res 1988; 48: 5422-6
3. Kawa S, Oguchi H. Kobayashi T et al. Elevated serum levels of Dupan-2 in pancreatic cancer patients negative for Lewis blood group phenotype. Br / Cancer 1991; 64: 899-902